Advertisement

Topics

Danish Diabetes Biotech Rakes in $75M on NASDAQ in American IPO

02:37 EDT 9 Aug 2017 | Labiotech.eu

After announcing its intentions last month, Zealand Pharma has gone public in the US to fund its diabetes clinical trials. Zealand Pharma, a Glostrup-based biotech focused on peptide development for diabetes, has been public on the Danish Aktieselskabet exchange since 2011, ...

This awesome article Danish Diabetes Biotech Rakes in $75M on NASDAQ in American IPO appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Danish Diabetes Biotech Rakes in $75M on NASDAQ in American IPO

NEXT ARTICLE

More From BioPortfolio on "Danish Diabetes Biotech Rakes in $75M on NASDAQ in American IPO"

Quick Search
Advertisement
 

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...